Engineering Marker‐Free Lettuce Chloroplast Genome to Express Functional Glucagon‐Like Peptide‐1 Receptor Agonists Exenatide and Lixisenatide

Engineering of marker-free lettuce chloroplast genome to express CTB-Exenatide and CTB-Lixisenatide for oral delivery. Upper panel: Chemically synthesised exenatide or lixisenatide require expensive production, purification, refrigeration and invasive delivery methods. Lower panel: Exenatide or lixisenatide fusion with CTB expression in marker-free lettuce facilitates oral delivery and reduces cost by elimination of fermentation or chemical synthesis, […]

Five ways weight-loss jabs are changing spending habits – BBC

Five ways weight-loss jabs are changing spending habits  BBC Smaller portions, more protein: How GLP-1s are quietly changing chain restaurant menus  NBC News Gut-friendly foods: GLP-1 drives increased demand for fiber-rich options  Food Ingredients First How will weight-loss jabs change the food industry?  The Conversation Food companies are targeting users of weight-loss drugs with ‘GLP-1 Friendly’ labels  cherokeephoenix.org

The Seven Deadly Sins of Weight Loss Drugs

The Seven Deadly Sins of Weight Loss Drugs by Alan Cassels at Brownstone Institute O is for Obesity…. Back in the days, we saw a fat lady sing, Her song rich and lovely, our hearts would soon ring. And with her size so big, we silently mocked her,But we never thought once she should just see a […]

8 Medicare Changes Every Enrollee Should Know About in 2026

Key Points Some Medicare costs are going up — which is no suprise. Some costs, though, including some prescription drug costs, are going down. Original Medicare is testing prior authorizations, too. The $23,760 Social Security bonus most retirees completely overlook › According to the folks at Fidelity, a 65-year-old person who retired in 2025 could […]

Virginia university leads trial for post-GLP-1 weight drug

Fairfax, Va.-based George Mason University is leading a phase 2 clinical trial of ARD-201, an oral medication designed to help patients maintain weight loss after stopping GLP-1 treatments such as Ozempic and Wegovy. The university is one of six sites participating in the open-label trial of the experimental drug, developed by Aardvark Therapeutics, according to […]

Hormone therapy combined with tirzepatide linked to greater weight loss after menopause

A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking tirzepatide, a Food and Drug Administration-approved drug for the treatment of overweight and obesity. The findings, published in The Lancet Obstetrics, Gynaecology, & Women’s Health, could expand treatment possibilities for millions of women struggling with obesity and obesity-related diseases after menopause.